| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AXOGEN INC | 2,120,000 | 14,586,000 | 9.74% | ||
| 2 | MEDGENICS INC | 1,950,000 | 10,823,000 | 7.23% | ||
| 3 | ARIAD PHARMACEUTICALS INC | 1,250,000 | 9,238,000 | 6.17% | ||
| 4 | FIBROGEN INC COM | 330,000 | 5,415,000 | 3.62% | ||
| 5 | PROTALIX BIOTHERAPEUTICS INC | 8,200,000 | 5,248,000 | 3.51% | ||
| 6 | BLUEPRINT MEDICINES CORP COM | 250,000 | 5,063,000 | 3.38% | ||
| 7 | INOTEK PHARMACEUTICALS CORP | 645,000 | 4,799,000 | 3.21% | ||
| 8 | IMPRIMIS PHARMACEUTICALS INC | 1,267,500 | 4,766,000 | 3.18% | ||
| 9 | CODEXIS INC | 1,178,500 | 4,749,000 | 3.17% | ||
| 10 | ADAMAS PHARMACEUTICALS INC | 300,000 | 4,542,000 | 3.03% | ||
| 11 | Foamix Pharmaceuticals Ltd. | 695,000 | 4,413,000 | 2.95% | ||
| 12 | CARA THERAPEUTICS INC | 835,000 | 4,016,000 | 2.68% | ||
| 13 | AMARIN CORP PLC | 1,760,000 | 3,802,000 | 2.54% | ||
| 14 | AGIOS PHARMACEUTICALS INC | 85,000 | 3,561,000 | 2.38% | ||
| 15 | HORIZON PHARMA PLC | 200,000 | 3,294,000 | 2.20% | ||
| 16 | ULTRAGENYX PHARMACEUTICAL INC COM | 65,000 | 3,179,000 | 2.12% | ||
| 17 | MACROGENICS INC | 112,000 | 3,023,000 | 2.02% | ||
| 18 | IMMUNOMEDICS INC | 1,300,000 | 3,016,000 | 2.01% | ||
| 19 | Intec Pharma Ltd | 650,000 | 2,989,000 | 2.00% | ||
| 20 | AMAG PHARMACEUTICALS INC COM | 120,000 | 2,870,000 | 1.92% | ||
| 21 | CHIMERIX INC | 675,000 | 2,653,000 | 1.77% | ||
| 22 | SUPERNUS PHARMACEUTICALS INC COM | 125,000 | 2,546,000 | 1.70% | ||
| 23 | GLOBAL BLOOD THERAPEUTICS IN COM | 152,000 | 2,522,000 | 1.68% | ||
| 24 | XENON PHARMACEUTICALS INC | 410,000 | 2,419,000 | 1.62% | ||
| 25 | EDGE THERAPEUTICS INC | 225,600 | 2,281,000 | 1.52% | ||
| 26 | Lion Biotechnologies | 260,000 | 2,106,000 | 1.41% | ||
| 27 | CYNAPSUS THERAPEUTICS INC | 125,000 | 2,094,000 | 1.40% | ||
| 28 | PARATEK PHARMACEUTICALS INC | 146,700 | 2,041,000 | 1.36% | ||
| 29 | Nabriva Therapeutics AG | 270,000 | 2,025,000 | 1.35% | ||
| 30 | Aquinox Pharmaceuticals Inc | 295,000 | 1,953,000 | 1.30% | ||
| 31 | EAGLE PHARMACEUTICALS INC COM | 50,000 | 1,940,000 | 1.30% | ||
| 32 | ZOGENIX INC | 240,000 | 1,932,000 | 1.29% | ||
| 33 | TRILLIUM THERAPEUTICS INC | 195,000 | 1,751,000 | 1.17% | ||
| 34 | SERES THERAPEUTICS INC | 57,500 | 1,670,000 | 1.12% | ||
| 35 | CYTOMX THERAPEUTICS INC COM | 160,000 | 1,634,000 | 1.09% | ||
| 36 | TONIX PHARMACEUTICALS HLD | 800,000 | 1,592,000 | 1.06% | ||
| 37 | AFFIMED N V | 595,000 | 1,476,000 | 0.99% | ||
| 38 | INNOCOLL HLDGS PLC | 265,000 | 1,460,000 | 0.98% | ||
| 39 | AURIS MED HLDG AG | 340,000 | 1,425,000 | 0.95% | ||
| 40 | OCULAR THERAPEUTIX INC | 260,000 | 1,287,000 | 0.86% | ||
| 41 | PROTEOSTASIS THERAPEUTICS IN | 105,000 | 1,274,000 | 0.85% | ||
| 42 | CORIUM INTERNATIONAL INC | 360,000 | 1,249,000 | 0.83% | ||
| 43 | TENAX THERAPEUTICS INC COM | 465,000 | 1,190,000 | 0.79% | ||
| 44 | TG THERAPEUTICS INC COM | 175,000 | 1,061,000 | 0.71% | ||
| 45 | Evoke Pharma Inc | 130,000 | 891,000 | 0.60% | ||
| 46 | NEURODERM LTD | 52,500 | 853,000 | 0.57% | ||
| 47 | CIDARA THERAPEUTICS INC | 43,000 | 443,000 | 0.30% | ||
| 48 | ADAPTIMMUNE THERAPEUTICS PLC | 40,000 | 326,000 | 0.22% | ||
| 49 | BIOLINERX LTD | 250,000 | 223,000 | 0.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001546927-16-000514, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
